NCT05701007 2026-01-29Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in FinlandPfizerCompleted1,083 enrolled 29 charts
NCT06072196 2025-12-31A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)PfizerCompleted3,017 enrolled 5 charts
NCT04034095 2025-12-15A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in JapanJanssen Pharmaceutical K.K.Completed979 enrolled
NCT07086651 2025-12-08A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)PfizerCompleted1,300 enrolled
NCT05202301 2025-08-11A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication CompletelyBayerCompleted13,779 enrolled
NCT06151418 2025-06-04A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed ForcesPfizerCompleted2,313 enrolled 5 charts